ClinicalTrials.Veeva

Menu

Description of Therapy Options and Successes in the Long-term Course of Delirium in the Recovery Room - CESARO II

Charité University Medicine Berlin logo

Charité University Medicine Berlin

Status

Terminated

Conditions

Delirium

Study type

Observational

Funder types

Other

Identifiers

NCT04920734
CESARO-2

Details and patient eligibility

About

This project is a multicenter pilot project to evaluate the therapeutic success in the long term up to 3 months after a delirium in a recovery room. There is a Europe-wide recommendation for the prevention of postoperative delirium in older patients and the evidence and consensus-based guideline "Management of delirium, analgesia and sedation in intensiv care medicine" of the AWMF (Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften) are regularly updated for the detection and treatment of delirium in the intensive care unit. The aim is to evaluate the effects of a systematic delirium screening and the delirium treatment options in the long term in the same way as the current recommendations for the patient cohort of the recovery room.

Enrollment

5 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All patients admitted to the recovery room who have been diagnosed with delirium according to the treating physicians
  • The patient is on a ward in the hospital
  • Age ≥ 18 years
  • Stay in the recovery room ≥ 1 day
  • The patient is able to give consent

Exclusion criteria

  • Participation in a prospective intervention study (except adjuvant therapy study)
  • Patients with underlying neurological diseases that make it difficult to differentiate from delirium
  • Missing contact 3 months after stay in the recovery room.

Trial contacts and locations

1

Loading...

Central trial contact

Claudia Spies, MD, Prof.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems